Enrichment analysis of genes dysregulated following Lubiprostone treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013844
TitleEnrichment analysis of genes dysregulated following Lubiprostone treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Lubiprostone treated cells and untreated control cells.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3088060
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis CuratorAxel
CREEDS IDdrug:2778
Drug NameLubiprostone
DrugBank IDDB01046
Organismmouse
PubChem CID656719
SMILES IDCCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F
Characteristic Direction parameters
Control SamplesGSM457637, GSM457639
Perturbed SamplesGSM457638, GSM457640
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE18327
Gene Expression Omnibus
Lubiprostone effect on cystic fibrosis small intestine phenotype
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.